Abstract

Obesity and accompanying metabolic disease is negatively correlated with lung health yet the exact mechanisms by which obesity affects the lung are not well characterized. Since obesity is associated with lung diseases as chronic bronchitis and asthma, we designed a series of experiments to measure changes in lung metabolism in mice fed obesogenic diets. Mice were fed either control or high fat/sugar diet (45%kcal fat/17%kcal sucrose), or very high fat diet (60%kcal fat/7% sucrose) for 150 days. We performed untargeted metabolomics by GC-TOFMS and HILIC-QTOFMS and lipidomics by RPLC-QTOFMS to reveal global changes in lung metabolism resulting from obesity and diet composition. From a total of 447 detected metabolites, we found 91 metabolite and lipid species significantly altered in mouse lung tissues upon dietary treatments. Significantly altered metabolites included complex lipids, free fatty acids, energy metabolites, amino acids and adenosine and NAD pathway members. While some metabolites were altered in both obese groups compared to control, others were different between obesogenic diet groups. Furthermore, a comparison of changes between lung, kidney and liver tissues indicated few metabolic changes were shared across organs, suggesting the lung is an independent metabolic organ. These results indicate obesity and diet composition have direct mechanistic effects on composition of the lung metabolome, which may contribute to disease progression by lung-specific pathways.

Highlights

  • Obesity and metabolic syndrome are comorbidities often associated with various lung diseases, asthma

  • Feeding high fat/sugar (HFS) and very high fat (VHF) chow resulted in similar weight gain and body fat accumulation despite variations in fat and sugar content, and caloric contributions

  • Specific changes in the lung may contribute to the development or persistence of lung diseases such as asthma or chronic obstructive pulmonary disease (COPD), or to systemic conditions like metabolic syndrome

Read more

Summary

Introduction

Obesity and metabolic syndrome are comorbidities often associated with various lung diseases, asthma. There are many important outstanding questions that derive from these observations. It is still unclear how alterations in food intake or body mass index affect lung metabolism, and how differences in lung metabolite composition impact the persistence or progression of lung diseases like asthma. This knowledge gap creates challenges for clinicians looking to offer simple dietary recommendation to patients with complex diseases.

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call